1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Fuse Medical, Inc.

Fuse Medical, Inc.

FZMD
Fuse Medical, Inc.US flagOther OTC
0.02
USD
- -
- -
1.48MMarket Cap

Total Valuation

Fuse Medical, Inc. carries a market capitalization of 1.48M, placing it among publicly traded companies globally. Its enterprise value stands at 6.19M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.48M
Enterprise Value6.19M

Share Statistics

Fuse Medical, Inc. currently has 73.90M shares outstanding.

Shares Outstanding73.90M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Fuse Medical, Inc. trades at a trailing price-to-earnings ratio of 1.16. The price-to-sales ratio is 0.23, and the price-to-book ratio stands at -2.48.

PE Ratio1.16
PS Ratio0.23
PB Ratio-2.48
P/TBV Ratio-1.27
P/FCF Ratio234.61
P/OCF Ratio226.34

Enterprise Valuation

EV / Sales0.34
EV / EBITDAN/A
EV / EBITN/A
EV / FCF26.88

Financial Position

Fuse Medical, Inc. maintains a current ratio of 1.06, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -958.83, indicating conservative leverage, while an interest coverage ratio of -0.49 demonstrates limited ability to service its debt obligations.

Current Ratio1.06
Quick Ratio0.31
Debt / Equity-958.83
Debt / EBITDA-21.16
Interest Coverage-0.49

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)18.91
Return on Invested Capital (ROIC)-408.46
Return on Capital Employed (ROCE)-344.79
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.70

Taxes

Over the trailing twelve months, Fuse Medical, Inc. has paid 26,467.00 in income taxes, reflecting an effective tax rate of 0.72.

Income Tax26,467.00
Effective Tax Rate0.72

Stock Price Statistics

Fuse Medical, Inc.'s stock has declined approximately -80% over the past 52 weeks. The 50-day moving average sits at 0.03, while the 200-day moving average is 0.04.

Beta (5Y)N/A
52-Week Price Change-80%
50-Day Moving Average0.03
200-Day Moving Average0.04
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Fuse Medical, Inc. generated 18.40M in revenue and converted that into 3.63M in net income, yielding earnings per share of 0.05. EBITDA reached -104,965.00, while operating income came in at -239,702.00.

Revenue18.40M
Gross Profit11.95M
Operating Income-239,702.00
Pretax Income3.66M
Net Income3.63M
EBITDA-104,965.00
EBIT-239,702.00
Earnings Per Share (EPS)0.05

Balance Sheet

Fuse Medical, Inc. holds 253,378.00 in cash and equivalents against 2.22M in total debt, resulting in a net debt position of 1.97M. Total book value stands at -1.70M, with working capital of 754,339.00 providing operational flexibility.

Cash & Cash Equivalents253,378.00
Total Debt2.22M
Net Debt1.97M
Equity (Book Value)-1.70M
Book Value Per Share-0.02
Working Capital754,339.00

Cash Flow

Fuse Medical, Inc. produced 18,641.00 in operating cash flow over the past twelve months.

Operating Cash Flow18,641.00
Capital ExpendituresN/A
Free Cash Flow18,641.00
FCF Per Share0.00

Margins

Fuse Medical, Inc. operates with a gross margin of 64.95, reflecting its pricing power and cost economics. The operating margin of -1.30 and net profit margin of 19.72 provide insight into operational efficiency.

Gross Margin64.95
Operating Margin-1.30
Pretax Margin19.86
Profit Margin19.72
EBITDA Margin-0.57

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield8.75
FCF Yield0.43

Stock Splits

Fuse Medical, Inc.'s most recent stock split took place on May 30, 2014 with a 250:17 split ratio.

Last Split Date5/30/2014
Split Ratio250:17

Scores

Fuse Medical, Inc. posts an Altman Z-Score of 1.06, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.06